Back to:
NHS Tayside
Warning

NHS Tayside BNP Pathway flowchart and notes

Initial Primary Care assessment

  • Where heart failure is suspected perform clinical examination including ECG, chest x-ray, and FBC, U&E, LFT, glucose, TFT, +/- NTproBNP:  
    • If normal resting ECG without other clinical features suggestive of heart failure NTproBNP testing is not recommended. 
    • If LBBB or significant murmur is present request ECHO directly with ICE without need for BNP.  
    • If patient known to Cardiology department or echo within last 2 years please seek advice before requesting NT proBNP. 
    • NT pro BNP results should be treated with caution in the presence of co-morbidity, advanced age - see notes below re interpretation. 
    • Note that NTproBNP is now requested via ICE directly (no longer through transthoracic echo request algorithm). 

After NTproBNP consider need for ECHO referral:

    • f NTproBNP is less than 400ng/l - heart failure diagnosis unlikely - if normal ECG and no significant murmur ECHO not indicated.  
    • If NTproBNP 400-2000ng/L - consider heart failure as diagnosis, GP request ECHO via ICE, urgency dependent on clinical evaluation.  
    • If NTproBNP >2000ng/L - in absence of other causes heart failure likely, GP request URGENT ECHO via ICE if appropriate, based on clinical evaluation.  

Following ECHO:

Once patient has had ECHO, patient will be triaged directly by heart failure cardiologist to either clinic or advice depending on the result.  

Notes on interpreting NTproBNP

  • NTproBNP levels lower in certain conditions:  
    • High BMI. 
    • In patients already established on heart failure medications.
  • NTproBNP is higher in certain conditions:  
    • Aged over 70 years. 
    • Left ventricular hypertrophy, myocardial ischaemia, or tachycardia. 
    • Right ventricular overload/pulmonary hypertension/pulmonary embolism. 
    • Poor renal function (eGFR less than 60)
    • Infection. 
    • Chronic obstructive pulmonary disease (COPD)
    • Diabetes mellitus. 
    • Liver impairment. 

Editorial Information

Last reviewed: 14/11/2025

Next review date: 14/11/2027